RxAnte, Inc., a McLean, VA-based health care improvement company providing a new and innovative approach for improving medication adherence, has raised a Series A financing.
The round – whose amount was not disclosed – was led by Aberdare Ventures, with participation from the West Health Investment Fund.
The company intends to use the funding to further develop its proprietary technologies, and commercialize its current offerings.
Led by Dr. Josh Benner, Founder and CEO, RxAnte uses its patent-pending analytics platform to predict medication adherence for individual patients, target interventions to those most likely to benefit, and monitor and manage programs over time. Its system reveals which patients respond best to interventions, helping organizations improve the cost-effectiveness of their adherence improvement efforts.
The company is currently working with major health plans, providers, care management organizations and pharmaceutical companies. It is hiring (http://www.rxante.com/careers/)
FinSMEs
12/09/2012
Read our news on Facebook at: http://www.facebook.com/finsmes